Physician profile
Gregory Ewert
NPI 1376591974
$2,100.16
in general payments reported to CMS, 2019-2025
29 companies · $84.65 in 2025
The $84.65 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,570 · 2020: $302 · 2021: $34.87 · 2022: $69.78 · 2023: $38.92 · 2025: $84.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $285.33 | 2019-2025 | Wegovy |
| Pfizer INC. | $282.29 | 2019-2022 | |
| Amgen INC. | $179.08 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $175.14 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.16 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $122.99 | 2019-2023 | Eliquis |
| Csl Behring | $103.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $101.97 | 2019-2025 | Gardasil 9, Capvaxive |
| Janssen Pharmaceuticals, INC | $74.59 | 2019 | |
| Glaxosmithkline, LLC. | $66.87 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $64.40 | 2019 | |
| Alk-Abello, INC | $63.61 | 2019-2020 | |
| Lilly USA, LLC | $62.08 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.16 | 2019 | |
| Abbvie INC. | $36.69 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $33.02 | 2019 | |
| Seqirus USA INC | $31.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.50 | 2019-2020 | |
| Abbott Laboratories | $27.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $24.15 | 2019 | |
| Astellas Pharma US INC | $21.31 | 2020 | |
| Ironwood Pharmaceuticals, INC | $20.00 | 2020 | |
| Medtronic USA, INC. | $17.67 | 2019 | |
| Shire North American Group INC | $17.44 | 2019 | |
| Radius Health, INC. | $17.44 | 2019 | |
| Kaleo, INC. | $16.30 | 2019 | |
| Pharming Healthcare, INC. | $15.70 | 2019 | |
| Gilead Sciences, INC. | $14.59 | 2019 | |
| Dynavax Technologies Corporation | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ewert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.